AGL 39.50 Decreased By ▼ -0.50 (-1.25%)
AIRLINK 129.00 Decreased By ▼ -0.06 (-0.05%)
BOP 6.65 Decreased By ▼ -0.10 (-1.48%)
CNERGY 4.73 Increased By ▲ 0.24 (5.35%)
DCL 8.40 Decreased By ▼ -0.15 (-1.75%)
DFML 41.00 Increased By ▲ 0.18 (0.44%)
DGKC 80.75 Decreased By ▼ -0.21 (-0.26%)
FCCL 32.37 Decreased By ▼ -0.40 (-1.22%)
FFBL 74.98 Increased By ▲ 0.55 (0.74%)
FFL 11.53 Decreased By ▼ -0.21 (-1.79%)
HUBC 109.21 Decreased By ▼ -0.37 (-0.34%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.22 Decreased By ▼ -0.09 (-1.69%)
KOSM 7.51 Decreased By ▼ -0.21 (-2.72%)
MLCF 38.25 Decreased By ▼ -0.35 (-0.91%)
NBP 63.30 Decreased By ▼ -0.21 (-0.33%)
OGDC 192.30 Decreased By ▼ -2.39 (-1.23%)
PAEL 25.49 Decreased By ▼ -0.22 (-0.86%)
PIBTL 7.31 Decreased By ▼ -0.08 (-1.08%)
PPL 153.50 Decreased By ▼ -1.95 (-1.25%)
PRL 25.35 Decreased By ▼ -0.44 (-1.71%)
PTC 17.00 Decreased By ▼ -0.50 (-2.86%)
SEARL 77.71 Decreased By ▼ -0.94 (-1.2%)
TELE 7.55 Decreased By ▼ -0.31 (-3.94%)
TOMCL 33.27 Decreased By ▼ -0.46 (-1.36%)
TPLP 8.27 Decreased By ▼ -0.13 (-1.55%)
TREET 15.95 Decreased By ▼ -0.32 (-1.97%)
TRG 57.25 Decreased By ▼ -0.97 (-1.67%)
UNITY 27.78 Increased By ▲ 0.29 (1.05%)
WTL 1.39 No Change ▼ 0.00 (0%)
BR100 10,440 Decreased By -5.3 (-0.05%)
BR30 31,163 Decreased By -26.8 (-0.09%)
KSE100 97,184 Decreased By -614.5 (-0.63%)
KSE30 30,261 Decreased By -219.2 (-0.72%)

The Pfizer, Pakistan has announced to continue its grant for free treatment of the kidney patients at the Kidney Centre here under the National Dialysis Treatment Services (NDTS).
The NDTS was initiated to sponsor free treatment for Chronic Renal Failure (CRF) patients, who could not afford the life saving and expensive treatment of dialysis. Over 1,800 patients all over the country, registered with this programme, were supposed to be provided free treatment under the NDTS.
Due to its financial and other constraints, the NDTS programme was in jeopardy and the patients were suffering, as they could not continue with their life-saving treatment.
Understanding and sympathising with the plight of these patients, the Ministry of Health approached the pharmaceutical industry for help.
The Pfizer, Pakistan, in collaboration with the Ministry of Health, requested the Pfizer Global Philanthropy Programme to help and initiate the treatment of 100 dialysis patients under the government's National Dialysis Treatment Program in 2002.
A donation of over Rs 10 million was handed over to the Kidney Centre's Post-graduate Institute, Karachi, to support these patients.

Copyright Pakistan Press International, 2004

Comments

Comments are closed.